Cas:20261-65-8 2,2´-diamino-6,6´-dimethylbiphenyl manufacturer & supplier

Chemical Name:2,2´-diamino-6,6´-dimethylbiphenyl

CAS.NO:20261-65-8

Synonyms:6,6′-dimethylbiphenyl-2,2′-diamine;6.6-dimethyl-1-vinylcyclohexene;vinylcyclohexene;biphenyl-2,2′-diamine, 6,6′-dimethyl-;1-ethenyl-6,6-dimethyl-cyclohexene;Cyclohexene,1-ethenyl-6,6-dimethyl;6,6′-Dimethyl-2,2′-biphenyldiamine;[1,1′-Biphenyl]-2,2′-diamine, 6,6′-dimethyl-;2,2´-diamino-6,6´-dimethylbiphenyl;(+-)-6,6′-Dimethyl-biphenyl-2,2′-diyldiamin;6,6′-dimethyl-biphenyl-2,2′-diyldiamine

Molecular Formula:C₁₄H₁₆N₂

Molecular Weight:212.290

HS Code:2921590090

Physical and Chemical Properties:

Melting point:133-135ºC

Boiling point:339.4±37.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.638

PSA:52.04000

Exact Mass:212.131348

LogP:2.31

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6,6′-dimethylbiphenyl-2,2′-diamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6,6′-dimethyl-biphenyl-2,2′-diyldiamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-ethenyl-6,6-dimethyl-cyclohexene Use and application,2,2´-diamino-6,6´-dimethylbiphenyl technical grade,usp/ep/jp grade.

Related News: One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. 2,2´-diamino-6,6´-dimethylbiphenyl manufacturer Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added. 2,2´-diamino-6,6´-dimethylbiphenyl supplier After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. 2,2´-diamino-6,6´-dimethylbiphenyl vendor The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 2,2´-diamino-6,6´-dimethylbiphenyl factory One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively.